Navigation Links
Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
Date:2/5/2008

NAPA, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced the debut of Pyratine-6(TM) at the 66th Annual Meeting of the American Academy of Dermatology in San Antonio, Texas.

Pyratine-6(TM), Senetek's exclusive second generation cytokinin, has been clinically proven to be effective in correcting visible signs of skin aging and significantly reducing erythema as early as two weeks from onset of use.

The Annual Meeting of the American Academy of Dermatology runs from February 1 - 5, 2008. Approximately 7,000 medical personnel are registered to attend.

Commenting on the debut, Mr. Frank Massino, Senetek's Chairman and Chief Executive Officer stated, "We are delighted to see this compelling therapeutic come to the market and are very pleased by the reception Pyratine-6(TM) has received from dermatologists at this important conference. Pyratine-6(TM) has been successfully clinically tested and has shown attributes more beneficial to treatment than any predecessor compound."

About Senetek PLC

Senetek PLC (OTC Bulletin Board: SNKTY) is a Life Sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The Company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of the best-selling anti-aging product sold in the North American physician market.

For more information, visit the company's website at http://www.senetekplc.com.

This news release contains statements that may be considered 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act. Forward-looking statements by their nature involve substantial uncertainty, and actual results may differ materially from those that might be suggested by such statements. Important factors identified by the Company that it believes could result in such material differences are described in the Company's Annual Report on Form 10-K for the year 2006. However, the Company necessarily can give no assurance that it has identified or will identify all of the factors that may result in any particular forward-looking statement materially differing from actual results, and the Company assumes no obligation to correct or update any forward-looking statements which may prove to be inaccurate, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Senetek PLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Senetek PLC Reports Third Quarter 2007 Financial Results
2. Coherent Announces Director Slate for Upcoming Annual Meeting
3. MAP Pharmaceuticals Announces Resignation of Chief Medical Officer
4. CorVel Announces Record Earnings Per Share
5. Better Nutrition Announces Best Of Beauty Awards Winners Showcasing the Best Natural Beauty Products of 2008
6. Naviscan Announces a New Chairman and Board Member
7. Globus Medical Announces Record Revenue for 2007
8. HealthFitness Announces Executive Changes: Chief Operations Officer And New Medical Officer Appointed; Vice Chairman Retires
9. Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008
10. Sergeants(R) Pet Care Products Announces Cause Marketing Partnership With the National Wildlife Federation
11. Poniard Pharmaceuticals Announces Upcoming Conference Participation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... NJ (PRWEB) , ... September 26, 2017 , ... ... trained orthopedic surgeon and the Chair of the Leg, Ankle, and Foot Section ... is currently the only fellowship trained orthopedic surgeon at Hackensack UMC performing total ...
(Date:9/26/2017)... ... 2017 , ... The 2017 American Academy of Cosmetic Surgery World Congress on ... only the latest about cosmetic procedures to remove and replace fat, but also how ... “Fat really is magical, especially when it comes to the cosmetic patient,” says cosmetic ...
(Date:9/26/2017)... Pittsburgh, PA (PRWEB) , ... September 26, 2017 ... ... new chairmen who are collaborating on strategic and tactical plans for Pittcon 2018. ... Chemistry), took office as president along with his named vice president, Charles Gardner, ...
(Date:9/26/2017)... ... ... Morning Sunshine!: Finding Strength and Comfort in God”: a hopeful and compelling story ... God” is the creation of published author, Terri Braun, a mother of two with ... local mental health center for over twenty years, helping the severely and persistently mentally ...
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... “Sound of ... Song” is the creation of published author, Karmen Worden, a retired teacher with a ... Worden’s new book is an intriguing and inspiring story on loss, living with depression, ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: